^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    ondansetron intravenous

    Associations

    News

    Trials
    Company:
    Generic mfg.
    Drug class:
    Serotonin 3 receptor antagonist
    Related drugs:
    Associations

    News

    Trials
    5d
    NELCER: Radiosensitizing Effect of Nelfinavir in Locally Advanced Carcinoma of Cervix (clinicaltrials.gov)
    P3, N=348, Active, not recruiting, Tata Memorial Hospital | Trial completion date: Jan 2026 --> Apr 2026
    Trial completion date
    |
    cisplatin • Viracept (nelfinavir) • ondansetron intravenous
    5d
    131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma (clinicaltrials.gov)
    P2, N=62, Active, not recruiting, Pediatric Brain Tumor Consortium | Trial completion date: Oct 2030 --> Sep 2027 | Trial primary completion date: Oct 2029 --> Mar 2026
    Trial completion date • Trial primary completion date
    |
    CD276 (CD276 Molecule)
    |
    Avastin (bevacizumab) • temozolomide • irinotecan • Omblastys (131I-omburtamab) • dexamethasone injection • ondansetron intravenous
    10d
    A study on the efficacy of aprepitant injection (submicron emulsion) in preventing postoperative nausea and vomiting in patients undergoing breast cancer surgery (ChiCTR2500113173)
    P4, N=300, Completed, Shanxi Provincial Cancer Hospital; Shanxi Provincial Cancer Hospital
    New P4 trial
    |
    ondansetron intravenous
    1m
    NELCER: Radiosensitizing Effect of Nelfinavir in Locally Advanced Carcinoma of Cervix (clinicaltrials.gov)
    P3, N=348, Active, not recruiting, Tata Memorial Hospital | Trial completion date: Sep 2025 --> Jan 2026
    Trial completion date
    |
    cisplatin • Viracept (nelfinavir) • ondansetron intravenous
    1m
    Extraskeletal Ewing Sarcoma Mimicking Benign Soft Tissue Tumors: A Rare Case. (PubMed, Cureus)
    Following multidisciplinary discussion, the patient was initiated on adjuvant chemotherapy using the CAV-IE (cyclophosphamide, doxorubicin, vincristine alternating with ifosfamide and etoposide), with a plan to complete 12 cycles, while radiotherapy was not indicated. She commenced her treatment with Cycle 1 of the IE component, accompanied by supportive care including intravenous fluids, ondansetron, omeprazole, and dexamethasone...She developed dysuria during hospitalization, and the treatment plan was adjusted to include an increased dose of mesna to enhance uroprotection. This case highlights the importance of considering EES in the differential diagnosis of persistent soft tissue masses, even in slow-growing lesions. It underscores the pivotal role of immunohistochemistry and multidisciplinary management in achieving a definitive diagnosis and favorable outcomes.
    Journal
    |
    KIT (KIT proto-oncogene, receptor tyrosine kinase) • BCL2 (B-cell CLL/lymphoma 2) • CCND1 (Cyclin D1) • VIM (Vimentin) • CD99 (CD99 Molecule)
    |
    doxorubicin hydrochloride • cyclophosphamide • ifosfamide • etoposide IV • vincristine • dexamethasone • mesna • omeprazole • ondansetron intravenous
    3ms
    Dexamethasone-Ondansetron Combined with Diphenhydramine for Preventing Postoperative Nausea and Vomiting in Thoracoscopic lung surgery: A double blind randomized controlled trial (ChiCTR2500110881)
    P=N/A, N=200, Not yet recruiting, Anesthesia and Surgery Center of West China Hospital Sichuan University; West China Hospital Sichuan University
    New trial
    |
    dexamethasone injection • ondansetron intravenous
    3ms
    Comparison of Aprepitant and Ondansetron for Postoperative Nausea and Vomiting after Laparoscopic Cholecystectomy (ChiCTR2500108960)
    P=N/A, N=310, Not yet recruiting, The First Affiliated Hospital with Nanjing Medical University; The First Affiliated Hospital with Nanjing Medical University
    New trial
    |
    ondansetron intravenous
    5ms
    Serratus Posterior Superior Plane Block for Postoperative Pain in Cardiac Surgery (clinicaltrials.gov)
    P=N/A, N=50, Recruiting, Ondokuz Mayıs University | Not yet recruiting --> Recruiting
    Enrollment open
    |
    dexamethasone injection • ondansetron intravenous
    5ms
    The Effect of Superficial Cervical Block Application on Postoperative Opioid Consumption in Patients Undergoing Anterior Cervical Discectomy Surgery (clinicaltrials.gov)
    P=N/A, N=60, Completed, Medipol University | Recruiting --> Completed | Trial completion date: Jun 2025 --> Sep 2025 | Trial primary completion date: Apr 2025 --> Aug 2025
    Trial completion • Trial completion date • Trial primary completion date
    |
    ondansetron intravenous
    5ms
    Serratus Posterior Superior Plane Block for Postoperative Pain in Cardiac Surgery (clinicaltrials.gov)
    P=N/A, N=50, Not yet recruiting, Ondokuz Mayıs University
    New trial
    |
    dexamethasone injection • ondansetron intravenous
    5ms
    Antiemetic Fosaprepitant To Remedy Nausea and Vomiting (clinicaltrials.gov)
    P2/3, N=250, Recruiting, Montefiore Medical Center | Trial completion date: May 2025 --> Jun 2026 | Trial primary completion date: May 2025 --> Jun 2026
    Trial completion date • Trial primary completion date
    |
    fosaprepitant • ondansetron intravenous
    6ms
    NELCER: Radiosensitizing Effect of Nelfinavir in Locally Advanced Carcinoma of Cervix (clinicaltrials.gov)
    P3, N=348, Active, not recruiting, Tata Memorial Hospital | Recruiting --> Active, not recruiting
    Enrollment closed
    |
    cisplatin • Viracept (nelfinavir) • ondansetron intravenous